603195.CG▲
Over 20 Shanghai-listed companies disclose buybacks, stake increases and restructuring positives in the evening
On the evening of September 28, more than 20 listed companies on the Shanghai Stock Exchange, including those on the STAR Market, released a batch of positive announcements covering share buybacks and stake increases, asset restructuring, drug approvals, and the signing of major operating contracts. Buybacks and stake increases were the highlight of the evening, with 12 companies publishing related plans or implementation progress. Among them, Huaqin Technology plans to use 300 million to 400 million yuan of its own funds to repurchase shares, with a buyback price cap of 100 yuan per share. Sifang Electric plans to spend 100 million to 150 million yuan on buybacks, with a price cap of 50 yuan per share. Jingsong Intelligent, which has already entered the implementation stage, completed its first buyback of 27,300 shares for 502,600 yuan. Haier Smart Home has repurchased a total of 108 million shares from March 27 to September 28 this year, spending 2.27 billion yuan. Bull Group has repurchased a total of 6.2046 million shares, using 245 million yuan. On the stake increase side, CCCC Design and Consulting's controlling shareholder CCCC Capital has increased its stake by a total of 15.3542 million shares since launching the increase on August 18, investing 80.36 million yuan and meeting the minimum amount required by the increase plan. In asset restructuring, Garden Corporation plans to issue shares and pay cash to acquire 93.5031 percent of Hualan Micro's shares while raising supporting funds. After the deal is completed, it will control this company engaged in the research, development and design of domestic storage controller chips, expanding its business into the storage chip sector. At the operating level, Jiangsu Jianyou Bio-Pharmaceutical's subsidiary received approval from the U.S. FDA for its vitamin B1 injection, with cumulative research and development investment of nearly 20 million yuan for the project. Shanghai Pharmaceuticals had multiple formulation products approved for production. China National Chemical Engineering announced total newly signed contracts of 238.797 billion yuan from January to August, and in August it secured several large orders including the general contracting of a gold mine in Saudi Arabia.
600690.CG · Capital · Positive Haier Smart Home repurchased 108 million shares for 2.27 billion yuan, a buyback that is positive for the stock.
601126.CG · Capital · Positive Sifang Electric plans to spend 100-150 million yuan on share buybacks, a positive capital event.
603195.CG · Capital · Positive Bull Group repurchased 6.2046 million shares for 245 million yuan, a positive buyback.
603296.CG · Capital · Positive Huaqin Technology plans to repurchase 300-400 million yuan of shares, a positive buyback.
688251.CG · Capital · Positive Jingsong Intelligent completed its first buyback of 27,300 shares for 502,600 yuan, a capital-return event.
中交资本 (CCCC Capital) · Capital · Positive CCCC Capital, controlling shareholder of CCCC Design and Consulting, increased its stake by 15.3542 million shares for 80.36 million yuan, meeting the plan's minimum.